Amazing news from Ionis and Roche! HTTRx drug successfully lowers harmful huntingtin protein in spinal fluid
CRISPR genome editing just got an off-switch. We cut through the hype to explore the technology in HD
Can we test drugs to delay or prevent the onset of Huntington's disease? New research suggests it's possible
Ionis says its trial of HTTRx, intended to lower huntingtin protein, is fully recruited and plans to extend it
Completely removing normal huntingtin in adults may disrupt healthy brain function, a recent study suggests.
WAVE Life Sciences launches PRECISION clinical trial to suppress the mutant Huntington's disease protein
Evolving CRISPR-Cas9 techniques can now be used to edit the HD gene in a living mouse brain.
A potential HD biomarker has been uncovered in a recent clinical study
Media reports of a wonder drug for neurodegenerative diseases like Huntington's disease are overhyped
HDBuzz summarises final day of the 2017 Huntington's Disease Therapeutics Conference in Malta
HDBuzz summarises all the science from the 2017 Huntington's Disease Therapeutics Conference in Malta - day 2